Cover Image
市場調查報告書

Armour Therapeutics Inc.:產品平台分析

Armour Therapeutics Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293986
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Armour Therapeutics Inc.:產品平台分析 Armour Therapeutics Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月12日 內容資訊: 英文 21 Pages
簡介

Armour Therapeutics Inc.是正在開發生殖組織癌用抗荷爾蒙治療藥的生物製藥公司。該公司的抗荷爾蒙治療可因應前列腺癌及轉移性前列腺癌的所有病期。

這份報告提供Armour Therapeutics Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Armour Therapeutics Inc.的基本資料

  • Armour Therapeutics Inc.概要
  • 主要資訊
  • 企業資料

Armour Therapeutics Inc.:R&D概要

  • 主要的治療範圍

Armour Therapeutics Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Armour Therapeutics Inc.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Armour Therapeutics Inc.:藥物簡介

  • AT-001
  • AT-012
  • AT-027

Armour Therapeutics Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Armour Therapeutics Inc.:最近的開發平台趨勢

Armour Therapeutics Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07496CDB

Summary

Global Markets Direct's, 'Armour Therapeutics Inc. - Product Pipeline Review - 2015', provides an overview of the Armour Therapeutics Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Armour Therapeutics Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Armour Therapeutics Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Armour Therapeutics Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Armour Therapeutics Inc.'s pipeline products

Reasons to buy

  • Evaluate Armour Therapeutics Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Armour Therapeutics Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Armour Therapeutics Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Armour Therapeutics Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Armour Therapeutics Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Armour Therapeutics Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Armour Therapeutics Inc. Snapshot
    • Armour Therapeutics Inc. Overview
    • Key Information
    • Key Facts
  • Armour Therapeutics Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Armour Therapeutics Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Armour Therapeutics Inc. - Pipeline Products Glance
    • Armour Therapeutics Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Armour Therapeutics Inc. - Drug Profiles
    • AT-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AT-012
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AT-027
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Armour Therapeutics Inc. - Pipeline Analysis
    • Armour Therapeutics Inc. - Pipeline Products by Target
    • Armour Therapeutics Inc. - Pipeline Products by Route of Administration
    • Armour Therapeutics Inc. - Pipeline Products by Molecule Type
    • Armour Therapeutics Inc. - Pipeline Products by Mechanism of Action
  • Armour Therapeutics Inc. - Recent Pipeline Updates
  • Armour Therapeutics Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Armour Therapeutics Inc., Key Information
  • Armour Therapeutics Inc., Key Facts
  • Armour Therapeutics Inc. - Pipeline by Indication, 2015
  • Armour Therapeutics Inc. - Pipeline by Stage of Development, 2015
  • Armour Therapeutics Inc. - Monotherapy Products in Pipeline, 2015
  • Armour Therapeutics Inc. - Preclinical, 2015
  • Armour Therapeutics Inc. - Discovery, 2015
  • Armour Therapeutics Inc. - Pipeline by Target, 2015
  • Armour Therapeutics Inc. - Pipeline by Route of Administration, 2015
  • Armour Therapeutics Inc. - Pipeline by Molecule Type, 2015
  • Armour Therapeutics Inc. - Pipeline Products by Mechanism of Action, 2015
  • Armour Therapeutics Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Armour Therapeutics Inc. - Pipeline by Top 10 Indication, 2015
  • Armour Therapeutics Inc. - Pipeline by Stage of Development, 2015
  • Armour Therapeutics Inc. - Monotherapy Products in Pipeline, 2015
  • Armour Therapeutics Inc. - Pipeline by Top 10 Target, 2015
  • Armour Therapeutics Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top